Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
about
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapyInvestigating molecular profiles of ovarian cancer: an update on cancer stem cells.Oxaliplatin for the treatment of ovarian cancer.Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.Trial Watch: Chemotherapy with immunogenic cell death inducers.
P2860
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gemcitabine-oxaliplatin (GEMOX ...... elial ovarian cancer patients.
@en
Gemcitabine-oxaliplatin
@nl
type
label
Gemcitabine-oxaliplatin (GEMOX ...... elial ovarian cancer patients.
@en
Gemcitabine-oxaliplatin
@nl
prefLabel
Gemcitabine-oxaliplatin (GEMOX ...... elial ovarian cancer patients.
@en
Gemcitabine-oxaliplatin
@nl
P2093
P2860
P50
P356
P1476
Gemcitabine-oxaliplatin (GEMOX ...... helial ovarian cancer patients
@en
P2093
Cristina Vincenzoni
Federica Tomao
Giacomo Corrado
Giancarlo Paoletti
Laura Pizzuti
Luciano Mariani
Luigi Di Lauro
Maria Grazia Arena
Silverio Tomao
P2860
P2888
P356
10.1186/1756-9966-32-49
P577
2013-08-08T00:00:00Z
P5875
P6179
1043716721